Table 1 Characteristics of study population by treatment strategies
Variables | PCI (N = 1305) | CABG (N = 899) | MT (N = 913) | P value |
|---|---|---|---|---|
Age (Years) | 60.5 ± 10.1 | 61.3 ± 8.4 | 63.1 ± 9.8 | < 0.001 |
Body mass index (kg/m2) | 26.1 ± 2.9 | 25.9 ± 2.9 | 25.8 ± 3.1 | 0.163 |
Male | 977 (74.9) | 696 (77.4) | 660 (72.3) | 0.042 |
Hypertension history | 943 (72.3) | 632 (70.3) | 643 (70.4) | 0.514 |
Hyperlipidemia history | 791 (60.6) | 509 (56.6) | 546 (59.8) | 0.158 |
Chronic kidney disease history | 7 (0.5) | 15 (1.7) | 19 (2.1) | 0.004 |
COPD history | 13 (1.0) | 10 (1.1) | 16 (1.8) | 0.261 |
PAD history | 64 (4.9) | 121 (13.5) | 106 (11.6) | < 0.001 |
Smoking history | 673 (51.6) | 449 (49.9) | 474 (51.9) | 0.426 |
PCI history | 180 (13.8) | 88 (9.8) | 126 (13.8) | 0.842 |
CABG history | 49 (3.8) | 1 (0.1) | 55 (6.0) | 0.049 |
Revascularization history | 307 (46.2) | 130 (19.6) | 227 (34.2) | < 0.001 |
hsCRP (mg/L) | 3.9 ± 6.1 | 3.8 ± 5.4 | 4.2 ± 4.8 | 0.455 |
Creatinine clearance (mL/min) | 89.0 ± 28.5 | 86.8 ± 26.3 | 83.0 ± 28.2 | < 0.001 |
LVEF | 59.2 ± 8.8 | 57.8 ± 9.5 | 54.9 ± 11.7 | < 0.001 |
SYNTAX score | 22.2 ± 9.3 | 30.6 ± 9.2 | 26.3 ± 12.9 | < 0.001 |